Morgan Stanley raised the firm’s price target on Ryan Specialty (RYAN) to $67 from $65 and keeps an Overweight rating on the shares. The firm updated models in the insurance space post the Q3 reports. For property and casualty, Morgan Stanley sees a softening cycle heading into 2026, the analyst tells investors.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty price target lowered to $66 from $70 at BMO Capital
- Ryan Specialty price target lowered to $63 from $71 at Goldman Sachs
- Ryan Specialty price target lowered to $65 from $73 at Keefe Bruyette
- Ryan Specialty Group’s Earnings Call: Growth Amid Challenges
- Ryan Specialty Group: Strong Organic Growth and Strategic Investments Justify Buy Rating